Complement C4d-specific antibodies for the diagnosis of lung cancer

Development of molecular markers that help to identify high-risk individuals or diagnose indeterminate pulmonary nodules could have a major impact on lung cancer clinical management. In this study, we evaluated the diagnostic potential of a newly-developed ELISA that specifically detects complement...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Ajona, Daniel, Okrój, Marcin, Pajares, María J., Agorreta, Jackeline, Lozano, María D., Zulueta, Javier J., Verri, Carla, Roz, Luca, Sozzi, Gabriella, Pastorino, Ugo, Massion, Pierre P., Montuenga, Luis M., Blom, Anna M., Pio, Ruben
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5814217/
https://ncbi.nlm.nih.gov/pubmed/29464077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23690
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados